Cargando…
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression
SIMPLE SUMMARY: Glioblastoma is the deadliest primary brain tumor. Current treatment strategies for glioblastoma are not effective, and patients exhibit poor survival rates. Emerging studies implicated glioma stem cells (GSCs) in tumor initiation, progression, and therapy resistance. There is an unm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093618/ https://www.ncbi.nlm.nih.gov/pubmed/37046668 http://dx.doi.org/10.3390/cancers15072008 |